ID   AT2B3_HUMAN             Reviewed;        1220 AA.
AC   Q16720; B7WNR8; B7WNY5; Q12995; Q16858;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 3.
DT   10-MAY-2017, entry version 170.
DE   RecName: Full=Plasma membrane calcium-transporting ATPase 3;
DE            Short=PMCA3;
DE            EC=3.6.3.8;
DE   AltName: Full=Plasma membrane calcium ATPase isoform 3;
DE   AltName: Full=Plasma membrane calcium pump isoform 3;
GN   Name=ATP2B3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS XA AND XB).
RC   TISSUE=Brain;
RX   PubMed=8765088; DOI=10.1016/0005-2736(96)00108-3;
RA   Brown B., Hilfiker H., Demarco S.J., Zacharias D.A., Greenwood T.M.,
RA   Carafoli E., Strehler E.E.;
RT   "Primary structure of human plasma membrane Ca(2+)-ATPase isoform 3.";
RL   Biochim. Biophys. Acta 1283:10-13(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-319, AND ALTERNATIVE SPLICING
RP   (ISOFORMS XB/XA/XE/XG).
RX   PubMed=8187550;
RA   Wang M.G., Yi H., Hilfiker H., Carafoli E., Strehler E.E.,
RA   McBride O.W.;
RT   "Localization of two genes encoding plasma membrane Ca2+ ATPases
RT   isoforms 2 (ATP2B2) and 3 (ATP2B3) to human chromosomes 3p26-->p25 and
RT   Xq28, respectively.";
RL   Cytogenet. Cell Genet. 67:41-45(1994).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-1053, AND ALTERNATIVE SPLICING
RP   (ISOFORMS XB/XA/XE/XG).
RX   PubMed=10854409; DOI=10.1101/gr.10.6.758;
RA   Mallon A.-M., Platzer M., Bate R., Gloeckner G., Botcherby M.R.M.,
RA   Nordsiek G., Strivens M.A., Kioschis P., Dangel A., Cunningham D.,
RA   Straw R.N.A., Weston P., Gilbert M., Fernando S., Goodall K.,
RA   Hunter G., Greystrong J.S., Clarke D., Kimberley C., Goerdes M.,
RA   Blechschmidt K., Rump A., Hinzmann B., Mundy C.R., Miller W.,
RA   Poustka A., Herman G.E., Rhodes M., Denny P., Rosenthal A.,
RA   Brown S.D.M.;
RT   "Comparative genome sequence analysis of the Bpa/Str region in mouse
RT   and man.";
RL   Genome Res. 10:758-775(2000).
RN   [6]
RP   PARTIAL NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS XG/ZG AND XA/ZA), AND
RP   ALTERNATIVE SPLICING.
RC   TISSUE=Brain cortex;
RX   PubMed=8245032;
RA   Stauffer T.P., Hilfiker H., Carafoli E., Strehler E.E.;
RT   "Quantitative analysis of alternative splicing options of human plasma
RT   membrane calcium pump genes.";
RL   J. Biol. Chem. 268:25993-26003(1993).
RN   [7]
RP   ERRATUM.
RX   PubMed=7989379;
RA   Stauffer T.P., Hilfiker H., Carafoli E., Strehler E.E.;
RL   J. Biol. Chem. 269:32022-32022(1994).
RN   [8]
RP   INTERACTION WITH PDZD11.
RX   PubMed=12763866; DOI=10.1111/j.1749-6632.2003.tb07230.x;
RA   Goellner G.M., DeMarco S.J., Strehler E.E.;
RT   "Characterization of PISP, a novel single-PDZ protein that binds to
RT   all plasma membrane Ca2+-ATPase b-splice variants.";
RL   Ann. N. Y. Acad. Sci. 986:461-471(2003).
RN   [9]
RP   TISSUE SPECIFICITY, VARIANT SCAX1 ASP-1107, AND CHARACTERIZATION OF
RP   VARIANT SCAX1 ASP-1107.
RX   PubMed=22912398; DOI=10.1073/pnas.1207488109;
RA   Zanni G., Cali T., Kalscheuer V.M., Ottolini D., Barresi S.,
RA   Lebrun N., Montecchi-Palazzi L., Hu H., Chelly J., Bertini E.,
RA   Brini M., Carafoli E.;
RT   "Mutation of plasma membrane Ca2+ ATPase isoform 3 in a family with X-
RT   linked congenital cerebellar ataxia impairs Ca2+ homeostasis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:14514-14519(2012).
CC   -!- FUNCTION: This magnesium-dependent enzyme catalyzes the hydrolysis
CC       of ATP coupled with the transport of calcium out of the cell.
CC   -!- CATALYTIC ACTIVITY: ATP + H(2)O + Ca(2+)(Side 1) = ADP + phosphate
CC       + Ca(2+)(Side 2).
CC   -!- SUBUNIT: Interacts with PDZD11. {ECO:0000269|PubMed:12763866}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=8;
CC         Comment=There is a combination of two alternatively spliced
CC         domains at N-terminal site A (X and Z) and at C-terminal site C
CC         (A, B, E and G). The splice sites have mostly been studied
CC         independently. Full isoforms so far detected are isoform XA and
CC         isoform XB. Experimental confirmation may be lacking for some
CC         isoforms.;
CC       Name=XB; Synonyms=AIICI;
CC         IsoId=Q16720-1; Sequence=Displayed;
CC       Name=XA; Synonyms=AIICII;
CC         IsoId=Q16720-2; Sequence=VSP_000393;
CC       Name=ZA; Synonyms=AICII;
CC         IsoId=Q16720-3; Sequence=VSP_000392, VSP_000393;
CC       Name=ZB; Synonyms=AICI;
CC         IsoId=Q16720-4; Sequence=VSP_000392;
CC       Name=XE; Synonyms=AIICV;
CC         IsoId=Q16720-5; Sequence=VSP_000394;
CC       Name=ZE; Synonyms=AICV;
CC         IsoId=Q16720-6; Sequence=VSP_000392, VSP_000394;
CC       Name=XG; Synonyms=AIICVII;
CC         IsoId=Q16720-7; Sequence=VSP_000395;
CC       Name=ZG; Synonyms=AICVII;
CC         IsoId=Q16720-8; Sequence=VSP_000392, VSP_000395;
CC   -!- TISSUE SPECIFICITY: Highly expressed in the cerebellum,
CC       particulary in the presynaptic terminals of parallel fibers-
CC       Purkinje neurons. Isoform XE and isoform XB are the most abundant
CC       isoforms and are detected at low levels in brain and fetal
CC       skeletal muscle. The other isoforms are only found at lower levels
CC       and not in fetal tissues. {ECO:0000269|PubMed:22912398}.
CC   -!- DISEASE: Spinocerebellar ataxia, X-linked 1 (SCAX1) [MIM:302500]:
CC       Spinocerebellar ataxia is a clinically and genetically
CC       heterogeneous group of cerebellar disorders. Patients show
CC       progressive incoordination of gait and often poor coordination of
CC       hands, speech and eye movements, due to degeneration of the
CC       cerebellum with variable involvement of the brainstem and spinal
CC       cord. SCAX1 is characterized by hypotonia at birth, delayed motor
CC       development, gait ataxia, difficulty standing, dysarthria, and
CC       slow eye movements. Brain MRI shows cerebellar ataxia.
CC       {ECO:0000269|PubMed:22912398}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the cation transport ATPase (P-type)
CC       (TC 3.A.3) family. Type IIB subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U57971; AAB09762.1; -; mRNA.
DR   EMBL; U60414; AAB38530.1; -; mRNA.
DR   EMBL; AH006061; AAC15078.1; -; Genomic_DNA.
DR   EMBL; CH471172; EAW72859.1; -; Genomic_DNA.
DR   EMBL; U82695; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; U15689; AAA60986.1; -; mRNA.
DR   EMBL; U15690; AAA60987.1; -; mRNA.
DR   CCDS; CCDS14722.1; -. [Q16720-2]
DR   CCDS; CCDS35440.1; -. [Q16720-1]
DR   RefSeq; NP_001001344.1; NM_001001344.2. [Q16720-1]
DR   RefSeq; NP_068768.2; NM_021949.3. [Q16720-2]
DR   RefSeq; XP_005274747.1; XM_005274690.3. [Q16720-1]
DR   RefSeq; XP_005274748.1; XM_005274691.3. [Q16720-4]
DR   RefSeq; XP_005274749.1; XM_005274692.3. [Q16720-2]
DR   UniGene; Hs.533956; -.
DR   UniGene; Hs.658008; -.
DR   ProteinModelPortal; Q16720; -.
DR   BioGrid; 106982; 34.
DR   IntAct; Q16720; 2.
DR   MINT; MINT-2807671; -.
DR   STRING; 9606.ENSP00000263519; -.
DR   iPTMnet; Q16720; -.
DR   PhosphoSitePlus; Q16720; -.
DR   SwissPalm; Q16720; -.
DR   BioMuta; ATP2B3; -.
DR   DMDM; 116241261; -.
DR   EPD; Q16720; -.
DR   MaxQB; Q16720; -.
DR   PaxDb; Q16720; -.
DR   PeptideAtlas; Q16720; -.
DR   PRIDE; Q16720; -.
DR   Ensembl; ENST00000263519; ENSP00000263519; ENSG00000067842. [Q16720-1]
DR   Ensembl; ENST00000349466; ENSP00000343886; ENSG00000067842. [Q16720-1]
DR   Ensembl; ENST00000359149; ENSP00000352062; ENSG00000067842. [Q16720-2]
DR   Ensembl; ENST00000370186; ENSP00000359205; ENSG00000067842. [Q16720-3]
DR   Ensembl; ENST00000393842; ENSP00000377425; ENSG00000067842. [Q16720-6]
DR   GeneID; 492; -.
DR   KEGG; hsa:492; -.
DR   UCSC; uc004fhs.2; human. [Q16720-1]
DR   CTD; 492; -.
DR   DisGeNET; 492; -.
DR   GeneCards; ATP2B3; -.
DR   H-InvDB; HIX0017131; -.
DR   HGNC; HGNC:816; ATP2B3.
DR   HPA; HPA001583; -.
DR   MalaCards; ATP2B3; -.
DR   MIM; 300014; gene.
DR   MIM; 302500; phenotype.
DR   neXtProt; NX_Q16720; -.
DR   OpenTargets; ENSG00000067842; -.
DR   Orphanet; 85142; Aldosterone-producing adenoma.
DR   Orphanet; 314978; X-linked non progressive cerebellar ataxia.
DR   PharmGKB; PA25109; -.
DR   eggNOG; KOG0204; Eukaryota.
DR   eggNOG; ENOG410XNNC; LUCA.
DR   GeneTree; ENSGT00510000046331; -.
DR   HOGENOM; HOG000265623; -.
DR   HOVERGEN; HBG061286; -.
DR   InParanoid; Q16720; -.
DR   KO; K05850; -.
DR   OMA; GNPIFCT; -.
DR   OrthoDB; EOG091G057D; -.
DR   PhylomeDB; Q16720; -.
DR   TreeFam; TF300330; -.
DR   BRENDA; 3.6.3.8; 2681.
DR   Reactome; R-HSA-418359; Reduction of cytosolic Ca++ levels.
DR   Reactome; R-HSA-5578775; Ion homeostasis.
DR   Reactome; R-HSA-936837; Ion transport by P-type ATPases.
DR   ChiTaRS; ATP2B3; human.
DR   GeneWiki; ATP2B3; -.
DR   GenomeRNAi; 492; -.
DR   PRO; PR:Q16720; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000067842; -.
DR   CleanEx; HS_ATP2B3; -.
DR   Genevisible; Q16720; HS.
DR   GO; GO:1903561; C:extracellular vesicle; IDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:HPA.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IDA:SynGO-UCL.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0015085; F:calcium ion transmembrane transporter activity; IDA:SynGO-UCL.
DR   GO; GO:0005388; F:calcium-transporting ATPase activity; IBA:GO_Central.
DR   GO; GO:0005516; F:calmodulin binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0030165; F:PDZ domain binding; IBA:GO_Central.
DR   GO; GO:1990034; P:calcium ion export from cell; IDA:SynGO-UCL.
DR   GO; GO:0006874; P:cellular calcium ion homeostasis; IBA:GO_Central.
DR   GO; GO:0034220; P:ion transmembrane transport; TAS:Reactome.
DR   GO; GO:1903779; P:regulation of cardiac conduction; TAS:Reactome.
DR   GO; GO:0051480; P:regulation of cytosolic calcium ion concentration; IDA:SynGO-UCL.
DR   GO; GO:0006810; P:transport; TAS:ProtInc.
DR   Gene3D; 1.20.1110.10; -; 3.
DR   Gene3D; 3.40.1110.10; -; 2.
DR   InterPro; IPR022141; ATP_Ca_trans_C.
DR   InterPro; IPR006068; ATPase_P-typ_cation-transptr_C.
DR   InterPro; IPR004014; ATPase_P-typ_cation-transptr_N.
DR   InterPro; IPR023299; ATPase_P-typ_cyto_domN.
DR   InterPro; IPR018303; ATPase_P-typ_P_site.
DR   InterPro; IPR023298; ATPase_P-typ_TM_dom.
DR   InterPro; IPR008250; ATPase_P-typ_transduc_dom_A.
DR   InterPro; IPR023214; HAD-like_dom.
DR   InterPro; IPR006408; P-type_ATPase_IIB.
DR   InterPro; IPR001757; P_typ_ATPase.
DR   Pfam; PF12424; ATP_Ca_trans_C; 1.
DR   Pfam; PF00689; Cation_ATPase_C; 1.
DR   Pfam; PF00690; Cation_ATPase_N; 1.
DR   Pfam; PF00122; E1-E2_ATPase; 2.
DR   Pfam; PF08282; Hydrolase_3; 1.
DR   SMART; SM00831; Cation_ATPase_N; 1.
DR   SUPFAM; SSF56784; SSF56784; 2.
DR   SUPFAM; SSF81660; SSF81660; 1.
DR   TIGRFAMs; TIGR01517; ATPase-IIB_Ca; 1.
DR   TIGRFAMs; TIGR01494; ATPase_P-type; 3.
DR   PROSITE; PS00154; ATPASE_E1_E2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Calcium; Calcium transport;
KW   Calmodulin-binding; Cell membrane; Complete proteome;
KW   Disease mutation; Hydrolase; Ion transport; Magnesium; Membrane;
KW   Metal-binding; Neurodegeneration; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Reference proteome; Transmembrane; Transmembrane helix;
KW   Transport.
FT   CHAIN         1   1220       Plasma membrane calcium-transporting
FT                                ATPase 3.
FT                                /FTId=PRO_0000046218.
FT   TOPO_DOM      1     97       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     98    118       Helical. {ECO:0000255}.
FT   TOPO_DOM    119    155       Extracellular. {ECO:0000255}.
FT   TRANSMEM    156    176       Helical. {ECO:0000255}.
FT   TOPO_DOM    177    364       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    365    384       Helical. {ECO:0000255}.
FT   TOPO_DOM    385    417       Extracellular. {ECO:0000255}.
FT   TRANSMEM    418    435       Helical. {ECO:0000255}.
FT   TOPO_DOM    436    849       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    850    869       Helical. {ECO:0000255}.
FT   TOPO_DOM    870    879       Extracellular. {ECO:0000255}.
FT   TRANSMEM    880    900       Helical. {ECO:0000255}.
FT   TOPO_DOM    901    920       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    921    943       Helical. {ECO:0000255}.
FT   TOPO_DOM    944    961       Extracellular. {ECO:0000255}.
FT   TRANSMEM    962    983       Helical. {ECO:0000255}.
FT   TOPO_DOM    984   1002       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1003   1024       Helical. {ECO:0000255}.
FT   TOPO_DOM   1025   1034       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1035   1056       Helical. {ECO:0000255}.
FT   TOPO_DOM   1057   1220       Cytoplasmic. {ECO:0000255}.
FT   REGION     1097   1114       Calmodulin-binding subdomain A.
FT                                {ECO:0000250}.
FT   REGION     1115   1124       Calmodulin-binding subdomain B.
FT                                {ECO:0000250}.
FT   COMPBIAS    297    300       Poly-Glu.
FT   COMPBIAS   1174   1179       Poly-Pro.
FT   ACT_SITE    473    473       4-aspartylphosphate intermediate.
FT                                {ECO:0000250}.
FT   METAL       794    794       Magnesium. {ECO:0000250}.
FT   METAL       798    798       Magnesium. {ECO:0000250}.
FT   MOD_RES       8      8       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q64568}.
FT   MOD_RES    1079   1079       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q64568}.
FT   MOD_RES    1113   1113       Phosphothreonine; by PKC. {ECO:0000250}.
FT   VAR_SEQ     306    319       Missing (in isoform ZA, isoform ZB,
FT                                isoform ZE and isoform ZG).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_000392.
FT   VAR_SEQ    1115   1220       IRVVKAFRSSLYEGLEKPESKTSIHNFMATPEFLINDYTHN
FT                                IPLIDDTDVDENEERLRAPPPPSPNQNNNAIDSGIYLTTHV
FT                                TKSATSSVFSSSPGSPLHSVETSL -> MEVVSTFKRSGSV
FT                                QGAVRRRSSVLSQLHDVTNLSTPTHAILSAANPTSAAGNPG
FT                                GESVP (in isoform XA and isoform ZA).
FT                                {ECO:0000303|PubMed:8765088}.
FT                                /FTId=VSP_000393.
FT   VAR_SEQ    1115   1220       IRVVKAFRSSLYEGLEKPESKTSIHNFMATPEFLINDYTHN
FT                                IPLIDDTDVDENEERLRAPPPPSPNQNNNAIDSGIYLTTHV
FT                                TKSATSSVFSSSPGSPLHSVETSL -> MEVVSTFKRSGSV
FT                                QGAVRRRSSVLSQLHDVTNLSTPTHAILSAANPTSAAGSES
FT                                (in isoform XE and isoform ZE).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_000394.
FT   VAR_SEQ    1115   1220       IRVVKAFRSSLYEGLEKPESKTSIHNFMATPEFLINDYTHN
FT                                IPLIDDTDVDENEERLRAPPPPSPNQNNNAIDSGIYLTTHV
FT                                TKSATSSVFSSSPGSPLHSVETSL -> VCWDGKKMLRTTE
FT                                VG (in isoform XG and isoform ZG).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_000395.
FT   VARIANT     198    198       I -> M (in dbSNP:rs2269409).
FT                                /FTId=VAR_027928.
FT   VARIANT    1107   1107       G -> D (in SCAX1; the mutant protein is
FT                                expressed at the plasma membrane but
FT                                shows impaired extrusion of intracellular
FT                                calcium with prolonged retention of
FT                                cytoplasmic calcium compared to wild-type
FT                                under physiologic conditions;
FT                                dbSNP:rs397514619).
FT                                {ECO:0000269|PubMed:22912398}.
FT                                /FTId=VAR_069308.
FT   CONFLICT    587    587       I -> V (in Ref. 1; AAB09762/AAB38530).
FT                                {ECO:0000305}.
FT   CONFLICT    654    654       S -> Y (in Ref. 1; AAB09762/AAB38530).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1220 AA;  134197 MW;  03B2BA8A0A33B193 CRC64;
     MGDMANSSIE FHPKPQQQRD VPQAGGFGCT LAELRTLMEL RGAEALQKIE EAYGDVSGLC
     RRLKTSPTEG LADNTNDLEK RRQIYGQNFI PPKQPKTFLQ LVWEALQDVT LIILEVAAIV
     SLGLSFYAPP GEESEACGNV SGGAEDEGEA EAGWIEGAAI LLSVICVVLV TAFNDWSKEK
     QFRGLQSRIE QEQKFTVIRN GQLLQVPVAA LVVGDIAQVK YGDLLPADGV LIQANDLKID
     ESSLTGESDH VRKSADKDPM LLSGTHVMEG SGRMVVTAVG VNSQTGIIFT LLGAGGEEEE
     KKDKKGKQQD GAMESSQTKA KKQDGAVAME MQPLKSAEGG EMEEREKKKA NAPKKEKSVL
     QGKLTKLAVQ IGKAGLVMSA ITVIILVLYF VIETFVVEGR TWLAECTPVY VQYFVKFFII
     GVTVLVVAVP EGLPLAVTIS LAYSVKKMMK DNNLVRHLDA CETMGNATAI CSDKTGTLTT
     NRMTVVQSYL GDTHYKEIPA PSALTPKILD LLVHAISINS AYTTKILPPE KEGALPRQVG
     NKTECALLGF VLDLKRDFQP VREQIPEDKL YKVYTFNSVR KSMSTVIRMP DGGFRLFSKG
     ASEILLKKCT NILNSNGELR GFRPRDRDDM VRKIIEPMAC DGLRTICIAY RDFSAGQEPD
     WDNENEVVGD LTCIAVVGIE DPVRPEVPEA IRKCQRAGIT VRMVTGDNIN TARAIAAKCG
     IIQPGEDFLC LEGKEFNRRI RNEKGEIEQE RLDKVWPKLR VLARSSPTDK HTLVKGIIDS
     TTGEQRQVVA VTGDGTNDGP ALKKADVGFA MGIAGTDVAK EASDIILTDD NFTSIVKAVM
     WGRNVYDSIS KFLQFQLTVN VVAVIVAFTG ACITQDSPLK AVQMLWVNLI MDTFASLALA
     TEPPTESLLL RKPYGRDKPL ISRTMMKNIL GHAVYQLAII FTLLFVGELF FDIDSGRNAP
     LHSPPSEHYT IIFNTFVMMQ LFNEINARKI HGERNVFDGI FSNPIFCTIV LGTFGIQIVI
     VQFGGKPFSC SPLSTEQWLW CLFVGVGELV WGQVIATIPT SQLKCLKEAG HGPGKDEMTD
     EELAEGEEEI DHAERELRRG QILWFRGLNR IQTQIRVVKA FRSSLYEGLE KPESKTSIHN
     FMATPEFLIN DYTHNIPLID DTDVDENEER LRAPPPPSPN QNNNAIDSGI YLTTHVTKSA
     TSSVFSSSPG SPLHSVETSL
//
